What is the most likely diagnosis and immediate first‑line management for a 21‑year‑old woman with acute generalized edema (facial swelling progressing to abdomen and lower extremities), decreased urine output, orthopnea that improves when upright, a non‑bloody productive cough, a two‑year history of dull global headaches with occasional vomiting, and a one‑year hyperpigmented malar‑type facial rash?

Most Likely Diagnosis and Immediate Management

This 21-year-old woman most likely has lupus nephritis (Class V or mixed class) presenting as nephrotic syndrome, and immediate management should prioritize loop diuretics (furosemide) twice daily with strict sodium restriction (<2 g/day) for edema control, while urgently obtaining kidney biopsy, quantified 24-hour urine protein, serology (ANA, anti-dsDNA, complement levels), and urine sediment analysis to confirm diagnosis and guide immunosuppressive therapy.

Clinical Reasoning

Diagnostic Considerations

The constellation of findings strongly suggests systemic lupus erythematosus (SLE) with lupus nephritis:

• Malar rash (hyperpigmented facial discoloration involving cheeks and nasal bridge for one year) is a classic SLE feature
• Acute nephrotic syndrome (facial edema progressing to generalized anasarca, decreased urine output over 12 days)
• Volume overload complications (orthopnea, dyspnea at rest, productive cough indicating pulmonary edema)
• Young woman (peak SLE demographic: women of childbearing age)
• Headaches with vomiting (possible CNS lupus or hypertension-related)

The two-day trial of spironolactone and furosemide without improvement indicates inadequate diuretic dosing and likely severe nephrotic syndrome requiring more aggressive management.

Immediate First-Line Management

1. Edema and Volume Overload (Life-Threatening Priority)

Loop diuretics are first-line for nephrotic syndrome edema 1:

• Furosemide: Start 40-80 mg IV or oral twice daily (not once daily as previously prescribed)
• Twice-daily dosing is superior to once-daily dosing 1
• Escalate dose until clinically significant diuresis achieved or maximum effective dose reached
• Monitor for hypokalemia, hyponatremia, and volume depletion 1

Sodium restriction is mandatory: <2.0 g/day (<90 mmol/day) 1

If inadequate response within 24-48 hours, add thiazide diuretic (e.g., metolazone 2.5-5 mg daily) for synergistic effect 1. The combination blocks both loop of Henle and distal tubule sodium reabsorption.

Critical pitfall: Do NOT start ACE inhibitors or ARBs in acute-onset nephrotic syndrome—these can cause acute kidney injury, especially in minimal change disease 1. Wait until diagnosis is confirmed and acute phase stabilizes.

2. Urgent Diagnostic Workup

Kidney biopsy is the gold standard and must be performed urgently 2:

• Differentiates lupus nephritis classes (treatment differs significantly)
• Rules out minimal change disease (steroid-responsive)
• Identifies focal segmental glomerulosclerosis

Quantify proteinuria with 24-hour urine collection 1:

• Protein-creatinine ratio alone is insufficient in nephrotic range
• Baseline proteinuria guides treatment intensity and prognosis

Urine sediment analysis 1:

• Look for dysmorphic RBCs, red cell casts, acanthocytes (glomerular disease markers)
• Absence of hematuria doesn't exclude lupus nephritis

Serologic testing:

• ANA, anti-dsDNA antibodies, complement C3/C4 levels
• Complete metabolic panel, albumin, lipid panel
• Hepatitis B/C, HIV screening (before immunosuppression)

Assess kidney function: Use CKD-EPI creatinine equation for eGFR 1, 2

3. Supportive Care for Complications

Monitor for thrombotic complications: Nephrotic syndrome increases thrombosis risk, especially with albumin <2.5 g/dL 3. Consider prophylactic anticoagulation if albumin severely low and patient immobile.

Blood pressure control: Target <120 mm Hg systolic once volume status normalized 1

Treat pulmonary edema aggressively: Oxygen, upright positioning, IV diuretics. Consider ICU admission if respiratory distress worsens.

Disease-Specific Treatment (After Diagnosis Confirmed)

If Lupus Nephritis Class V (Pure Membranous)

Nephrotic-range proteinuria requires combined immunosuppression 3:

• Glucocorticoids (moderate dose preferred over high dose)
• Plus mycophenolate mofetil (MMF) 2-3 g/day OR tacrolimus
• Voclosporin showed sustained proteinuria reduction in AURORA trials 3
• Hydroxychloroquine is mandatory for all SLE patients 3

Median time to proteinuria reduction <0.5 g/g is 3.6 months with voclosporin 3, so patience is required.

If Mixed Class or Proliferative Lupus Nephritis

More aggressive induction immunosuppression required (glucocorticoids plus cyclophosphamide or MMF), followed by maintenance therapy 3.

Common Pitfalls to Avoid

1. Inadequate diuretic dosing: Once-daily furosemide is insufficient in nephrotic syndrome 1. Use twice-daily dosing and escalate aggressively.

2. Starting ACE-I/ARB too early: Can precipitate AKI in acute nephrotic syndrome 1. Wait until diagnosis confirmed and patient stabilized.

3. Delaying kidney biopsy: Biopsy is essential—treatment differs dramatically between lupus nephritis classes, minimal change disease, and FSGS 2.

4. Ignoring thrombosis risk: Nephrotic syndrome is hypercoagulable. Monitor for DVT/PE, especially with severe hypoalbuminemia.

5. Misdiagnosing as "idiopathic edema": The malar rash, acute onset, and severity point to secondary glomerular disease, not idiopathic edema 4, 5.

6. Underestimating severity: Orthopnea and dyspnea at rest indicate life-threatening pulmonary edema requiring immediate intervention.

Monitoring Parameters

• Daily weights and strict intake/output
• Electrolytes (especially potassium, sodium) every 1-2 days initially
• Creatinine to monitor kidney function during diuresis
• Blood pressure multiple times daily
• Respiratory status continuously if pulmonary edema present